Edesa Biotech CEO Pardeep Nijhawan Purchases 153,550 Shares in Private Placement

Pardeep Nijhawan, Chief Executive Officer, Director, and greater than 10% owner of Edesa Biotech, Inc., purchased 153,550 common shares of the company in a private placement on June 16, 2026. The transaction was executed at $5.21 per share for an aggregate purchase price of $799,995.50. Following the transaction, Nijhawan's direct ownership increased to 884,684 shares. Additionally, he has indirect ownership through several entities: 402,702 shares held by Pardeep Nijhawan Medicine Professional Corporation, 32,609 shares held by The New Nijhawan Family Trust 2015, 32,013 shares held by The Digestive Health Clinic Inc., and 53,104 shares held by 1968160 Ontario Inc. The filing includes disclaimers regarding beneficial ownership of shares held by these entities, with Nijhawan stating he disclaims beneficial ownership except to the extent of his pecuniary interest.